Drug-eluting stents: a new treatment in the prevention of restenosis. Part I: Experimental studies.
Salu
Koen J
KJ
Division of Cardiology, University of Antwerp, Wilrijk, Belgium. koen.salu@ua.ac.be
Bosmans
Johan M
JM
Bult
Hidde
H
Vrints
Chris J
CJ
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D023903:Coronary Restenosis / Q000628:therapy*; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D017239:Paclitaxel / Q000008:administration & dosage / Q000627:therapeutic use; D020123:Sirolimus / Q000008:administration & dosage / Q000627:therapeutic use; D015607:Stents
D000893:Anti-Inflammatory Agents; D000925:Anticoagulants; D007166:Immunosuppressive Agents; D003907:Dexamethasone; D006493:Heparin; D017239:Paclitaxel; D020123:Sirolimus